Lung cancer is the second most form of cancers and remains the leading cause of cancer deaths. A variety of new treatments are helping to bring down the number of deaths from…
Category: Lung Cancer Drugs
Get an ideas about the lung cancer treatment drugs, here we provide only information about drugs not to advice them to take without proper doctor guideline. For information about lung cancer drugs browse.
FDA Approves Optune Luna for Metastatic NSCLC
U.S. based FDA has approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors for treatment of patients with metastatic non-small cell lung cancer and whose disease has progressed on or after platinum-based…
Hetronifly Recommended for Lung Cancer in European Markets
The Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion and recommended for grant of marketing authorization for the medicinal product, Hetronifly in European markets. It is intended…
Osimertinib Plus Chemo Approved as Ist-Line Treatment for Patients with Lung Cancer
Lung cancer is the leading cause of cancer deaths among both men and women. It broadly splits into NSCLC and small cell lung cancer. Osimertinib (Tagrisso) in combination with pemetrexed and platinum-containing…
FDA Grants Approval to Amgen’s Treatment for deadly form of Lung Cancer
Every year, about 35k Americans are diagnosed with small cell lung cancer and the cancer usually has spread beyong the lung by the time it gets detected. The Food and Drug Administration…
An Overview of Platinum-based Chemotherapy for Lung Cancer
Chemotherapy is one of the most common forms of cancers treatments. The medication aims at destroying cancer cells. Platinum-based chemotherapy drugs are used to treat various cancer types such as lung, breast,…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa Immunogene Therapy (quratusugene…
Lung Cancer Drug, Osimertinib, Drastically Reduces Death Risk after Surgery
Lung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is responsible for nearly a…
Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with brain metastases. Recent research has shown that patients with Epidermal Growth Factor…
FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with NSCLC (non-small cell lung cancer). This approval has been based on the…
U.S. FDA Approves Lung Cancer Drug, Adagrasib
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally advanced or metastatic non-small cell lung cancer in adults. This accelerated…
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…